Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., May 04, 2023 -- Galera Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that... | May 4, 2023